JP2014525465A5 - - Google Patents

Download PDF

Info

Publication number
JP2014525465A5
JP2014525465A5 JP2014528678A JP2014528678A JP2014525465A5 JP 2014525465 A5 JP2014525465 A5 JP 2014525465A5 JP 2014528678 A JP2014528678 A JP 2014528678A JP 2014528678 A JP2014528678 A JP 2014528678A JP 2014525465 A5 JP2014525465 A5 JP 2014525465A5
Authority
JP
Japan
Prior art keywords
aromatase inhibitor
treatment
entinostat
use according
days
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014528678A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014525465A (ja
JP6195384B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/053551 external-priority patent/WO2013033656A1/en
Publication of JP2014525465A publication Critical patent/JP2014525465A/ja
Publication of JP2014525465A5 publication Critical patent/JP2014525465A5/ja
Application granted granted Critical
Publication of JP6195384B2 publication Critical patent/JP6195384B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014528678A 2011-09-02 2012-08-31 乳癌の処置方法 Active JP6195384B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201161530873P 2011-09-02 2011-09-02
US61/530,873 2011-09-02
US201161532534P 2011-09-08 2011-09-08
US61/532,534 2011-09-08
US201161628999P 2011-11-12 2011-11-12
US61/628,999 2011-11-12
US201161568110P 2011-12-07 2011-12-07
US61/568,110 2011-12-07
PCT/US2012/053551 WO2013033656A1 (en) 2011-09-02 2012-08-31 Methods for the treatment of breast cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017084847A Division JP2017149761A (ja) 2011-09-02 2017-04-21 乳癌の処置方法

Publications (3)

Publication Number Publication Date
JP2014525465A JP2014525465A (ja) 2014-09-29
JP2014525465A5 true JP2014525465A5 (pt-PT) 2015-11-05
JP6195384B2 JP6195384B2 (ja) 2017-09-13

Family

ID=47756940

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014528678A Active JP6195384B2 (ja) 2011-09-02 2012-08-31 乳癌の処置方法
JP2017084847A Pending JP2017149761A (ja) 2011-09-02 2017-04-21 乳癌の処置方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017084847A Pending JP2017149761A (ja) 2011-09-02 2017-04-21 乳癌の処置方法

Country Status (15)

Country Link
US (2) US10226472B2 (pt-PT)
EP (2) EP2751267B1 (pt-PT)
JP (2) JP6195384B2 (pt-PT)
KR (1) KR101956861B1 (pt-PT)
CN (3) CN103906837A (pt-PT)
AU (2) AU2012301616B2 (pt-PT)
BR (1) BR112014005080A2 (pt-PT)
CA (1) CA2847348A1 (pt-PT)
EA (1) EA201201474A1 (pt-PT)
ES (1) ES2663407T3 (pt-PT)
GE (1) GEP201706612B (pt-PT)
HK (1) HK1254859A1 (pt-PT)
MX (1) MX358254B (pt-PT)
UA (6) UA124238U (pt-PT)
WO (1) WO2013033656A1 (pt-PT)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014005080A2 (pt) 2011-09-02 2017-03-28 Syndax Pharmaceuticals Inc métodos para o tratamento de câncer de mama
WO2014179738A1 (en) * 2013-05-03 2014-11-06 Syndax Pharmaceuticals, Inc. Methods for the treatment of cancer
US20180104232A1 (en) * 2015-03-12 2018-04-19 The University Of Chicago Methods for determining prognosis for breast cancer patients
CA2994731C (en) * 2015-09-02 2023-09-26 Syndax Pharmaceuticals, Inc. Selection of patients for combination therapy
EP3487492A4 (en) * 2016-07-20 2020-03-11 Eisai R&D Management Co., Ltd. USE OF ERIBULIN AND HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCER
KR102212699B1 (ko) 2019-08-12 2021-02-05 한국원자력의학원 유방암 예방 또는 치료용 조성물
US11636870B2 (en) 2020-08-20 2023-04-25 Denso International America, Inc. Smoking cessation systems and methods
US11813926B2 (en) 2020-08-20 2023-11-14 Denso International America, Inc. Binding agent and olfaction sensor
US11760170B2 (en) 2020-08-20 2023-09-19 Denso International America, Inc. Olfaction sensor preservation systems and methods
US11760169B2 (en) 2020-08-20 2023-09-19 Denso International America, Inc. Particulate control systems and methods for olfaction sensors
US11932080B2 (en) 2020-08-20 2024-03-19 Denso International America, Inc. Diagnostic and recirculation control systems and methods
US11881093B2 (en) 2020-08-20 2024-01-23 Denso International America, Inc. Systems and methods for identifying smoking in vehicles
US11828210B2 (en) 2020-08-20 2023-11-28 Denso International America, Inc. Diagnostic systems and methods of vehicles using olfaction

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328245A (en) 1981-02-13 1982-05-04 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4410545A (en) 1981-02-13 1983-10-18 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4409239A (en) 1982-01-21 1983-10-11 Syntex (U.S.A.) Inc. Propylene glycol diester solutions of PGE-type compounds
US6350458B1 (en) 1998-02-10 2002-02-26 Generex Pharmaceuticals Incorporated Mixed micellar drug deliver system and method of preparation
US8658773B2 (en) 2011-05-02 2014-02-25 Immunomedics, Inc. Ultrafiltration concentration of allotype selected antibodies for small-volume administration
WO2008021542A2 (en) * 2006-08-17 2008-02-21 Cell Signaling Technology, Inc. Lysine acteylation sites
WO2008154382A1 (en) * 2007-06-06 2008-12-18 University Of Maryland, Baltimore Hdac inhibitors and hormone targeted drugs for the treatment of cancer
GB2454118B (en) * 2007-06-06 2010-06-02 Univ Maryland Hdac inhibitors and hormone targeted drugs for the treatment of cancer
WO2009067500A1 (en) * 2007-11-19 2009-05-28 Syndax Pharmaceuticals, Inc. Administration of an inhibitor of hdac
CA2825969A1 (en) 2011-02-02 2012-08-09 Genentech, Inc. Dosing for treatment with anti-egfl7 antibodies
BR112014005080A2 (pt) 2011-09-02 2017-03-28 Syndax Pharmaceuticals Inc métodos para o tratamento de câncer de mama
CH706458B1 (fr) 2012-04-30 2017-05-15 Granit Tech Sa Procédé de cimentation pour le stockage de déchets.

Similar Documents

Publication Publication Date Title
JP2014525465A5 (pt-PT)
RU2708374C2 (ru) Комбинированная терапия для лечения рака
JP2019523295A5 (pt-PT)
DK2269603T3 (en) TREATMENT OF BREAST TUMORS WITH A RAPAMYCIN DERIVATIVE IN COMBINATION WITH EXEMESTAN
RU2018103064A (ru) Комбинация ингибитора hdac и анти-pd-l1-антитела для лечения злокачественной опухоли
KR20190132515A (ko) 간 질환을 치료하는 방법
BR112020016331A8 (pt) Métodos para tratar câncer com anticorpos anti-pd-1
EA201792541A3 (ru) Ингибиторы рециркуляции желчных кислот для лечения гиперхолемии и холестатического заболевания печени
RU2017134443A (ru) Способ лечения с применением традипитанта
JP2018508593A5 (pt-PT)
JP2015526458A5 (pt-PT)
EA200700500A1 (ru) Совокупность лекарственных форм и способ её введения
JP2013520442A5 (pt-PT)
JP2015505564A5 (pt-PT)
BR112014027010A2 (pt) uso de laquinimod de alta dose para tratamento de esclerose múltipla
JP2020502261A5 (pt-PT)
UA124238U (uk) Спосіб лікування раку молочної залози
RU2014117510A (ru) Лечение ревматоидного артрита
US20220265823A1 (en) Uses of myostatin antagonists, combinations containing them and uses thereof
JP2020500152A5 (pt-PT)
RU2016148441A (ru) Способ лечения pr-положительного люминального а-типа рака молочной железы ингибитором pi3k пиктилисибом
JP2011525174A5 (pt-PT)
Tsuchihashi et al. Role of predictive value of the modified Glasgow prognostic score for later-line chemotherapy in patients with metastatic colorectal cancer
Peng et al. Aspirin alleviates pulmonary fibrosis through PI3K/AKT/mTOR-mediated autophagy pathway
RU2721555C2 (ru) Композиции, содержащие 15-hepe, и способы лечения или предотвращения фиброза с применением указанных композиций